Minimally Invasive Treatments for Prostatic Enlargement
UroLift and Rezūm offer a middle ground between long-term medication and definitive surgery for BPH. Mr. Jesuraj provides honest, balanced guidance on whether these procedures are appropriate for your situation — and where more definitive treatment is the better choice.
Ⓘ AN HONEST STARTING POINT
Mr. Jesuraj does not perform UroLift or Rezūm himself. He will give you an objective, evidence-based assessment of all your options — and refer you to an appropriate specialist if you decide to proceed with one of them after full discussion of the evidence.
His personal recommendation for patients suitable for surgical treatment is Aquablation — a procedure with stronger long-term evidence and more durable outcomes. But the decision is always yours, made on the basis of complete information.
UNDERSTANDING THE OPTIONS
Where Minimally Invasive Procedures Fit
Benign prostatic hyperplasia (BPH) causes a spectrum of lower urinary tract symptoms from mild to severely disabling. Treatment options span from lifestyle modification and medication through to definitive surgical procedures.
Minimally invasive procedures like UroLift and Rezūm sit in a specific gap — between long-term medication that has failed or is not tolerated, and more definitive surgical treatment where symptoms are not yet severe enough to warrant it. They offer the appeal of a short, low-risk procedure — but this comes with important trade-offs in terms of durability of benefit, patient selection limitations, and the possibility of needing further treatment.
Understanding where these procedures fit — and where they do not — is essential before making a decision. Mr. Jesuraj believes in giving patients the full picture.
Lifestyle & Watchful Waiting
Fluid management, caffeine reduction, bladder retraining. For mild symptoms with no complications.
Minimally Invasive — UroLift & Rezūm
For men who cannot tolerate medication or in whom it has failed, but where symptoms are not yet severe enough for definitive surgery — or where ejaculatory preservation is an absolute priority.
Medical Therapy
Alpha-blockers (tamsulosin), 5-alpha reductase inhibitors (finasteride), combination therapy. For moderate symptoms.
Definitive Surgical Treatment
Aquablation, TURP, HoLEP — for significant symptoms, large prostates, or when durable long-term relief is the priority.
UroLift — Prostatic Urethral Lift
Mechanical retraction of obstructing prostatic lobes using small permanent implants
COMPARISON
UroLift vs Rezūm vs Aquablation
An honest comparison across the procedures — including the one Mr. Jesuraj recommends and performs.
| Factor | UroLift | Rezūm | Aquablation |
|---|---|---|---|
| Mechanism | Mechanical retraction — no tissue removal | Steam thermal ablation — tissue destroyed | Robotic waterjet — precise tissue excision, no heat |
| Median lobe | ✘ Not suitable | ✓ Yes | ✓ Yes — any anatomy |
| Prostate size | 30–80ml only | 30–150ml | All sizes including very large |
| Anaesthetic | Local or GA | Local or GA | Spinal or general anaesthetic |
| Post-op catheter | Usually none | 1–2 weeks required | 1–2 days |
| Time to benefit | 2–4 weeks | 4–12 weeks | Weeks |
| Ejaculation preserved | Most patients | Most patients | Significantly lower risk than TURP |
| Key trial evidence | L.I.F.T. RCT (vs sham) | Rezūm RCT — McVary et al. (vs sham) | WATER trial vs TURP · WATER II large prostates |
| Long-term evidence | 5 years — limited beyond this | 5 years — industry-sponsored | Robust — independent RCT vs TURP |
| 5-year re-treatment | ~13% (L.I.F.T.) | Reported low — longer-term data awaited | Very low — strong durability data |
| NICE approved | Yes | Yes (2018) | Yes — 2023 |
| Available at Tees Urology | Via referral to specialist | Via referral to specialist | ✓ Mr. Jesuraj performs |
Honest Guidance — Not a Procedure Recommendation
Mr. Jesuraj does not perform UroLift or Rezūm. This is a deliberate clinical decision — not a commercial one. He believes that for the majority of men suitable for surgical treatment of BPH, more definitive procedures offer significantly more durable outcomes.
However, minimally invasive procedures have a genuine and important role for men in the specific gap between medical therapy and definitive surgery. This includes men who:
“My job is to ensure every patient fully understands their options, the evidence supporting each, and the honest limitations — including that the WATER and WATER II trial data, which is the most robust independent RCT evidence for any of these procedures, relates to Aquablation versus TURP. In some patients, especially those presenting with retention of urine or high risk of bleeding, I would strongly recommend them to go for TURP or Holmium Laser Enucleation. The choice of treatment should be married up with the needs and wants of the individual patient. If after full discussion a patient chooses UroLift or Rezūm, I will arrange referral to an appropriate specialist. What I will not do is recommend a procedure I believe is less likely to give a durable result without being transparent about that.”
– Mr. Manohar Jesuraj, Consultant Urological Surgeon
Interested?
Book a consultation with Mr. Jesuraj to find out if you are a suitable candidate. Appointments available within days.
Treatments — Prostate & Bladder
Minimally Invasive Treatments for Prostatic Enlargement
UroLift and Rezūm offer a middle ground between long-term medication and definitive surgery for BPH. Mr. Jesuraj provides honest, balanced guidance on whether these procedures are appropriate for your situation — and where more definitive treatment is the better choice.
ⓘ An Honest Starting Point
Mr. Jesuraj does not perform UroLift or Rezūm himself. He will give you an objective, evidence-based assessment of all your options — and refer you to an appropriate specialist if you decide to proceed with one of them after full discussion of the evidence.
His personal recommendation for patients suitable for surgical treatment is Aquablation — a procedure with stronger long-term evidence and more durable outcomes. But the decision is always yours, made on the basis of complete information.
Understanding the Options
Where Minimally Invasive Procedures Fit
Benign prostatic hyperplasia (BPH) causes a spectrum of lower urinary tract symptoms from mild to severely disabling. Treatment options span from lifestyle modification and medication through to definitive surgical procedures.
Minimally invasive procedures like UroLift and Rezūm sit in a specific gap — between long-term medication that has failed or is not tolerated, and more definitive surgical treatment where symptoms are not yet severe enough to warrant it. They offer the appeal of a short, low-risk procedure — but this comes with important trade-offs in terms of durability of benefit, patient selection limitations, and the possibility of needing further treatment.
Understanding where these procedures fit — and where they do not — is essential before making a decision. Mr. Jesuraj believes in giving patients the full picture.
BPH Treatment Spectrum
Fluid management, caffeine reduction, bladder retraining. For mild symptoms with no complications.
Alpha-blockers (tamsulosin), 5-alpha reductase inhibitors (finasteride), combination therapy. For moderate symptoms.
For men who cannot tolerate medication or in whom it has failed, but where symptoms are not yet severe enough for definitive surgery — or where ejaculatory preservation is an absolute priority.
Aquablation, TURP, HoLEP — for significant symptoms, large prostates, or when durable long-term relief is the priority.
UroLift — Prostatic Urethral Lift
Mechanical retraction of obstructing prostatic lobes using small permanent implants
UroLift implants mechanically retract the enlarged prostate lobes to widen the urethral channel — no tissue is removed.
How It Works
UroLift uses small permanent implants — delivered cystoscopically — to retract and hold back the enlarged lateral lobes of the prostate, widening the urethral channel without removing any tissue. The procedure typically takes 30–60 minutes as a day case under local or general anaesthetic. There is no heat, cutting or tissue destruction.
Potential Advantages
- Preserves antegrade ejaculation in most patients
- Rapid recovery — often home same day
- No thermal injury to surrounding tissue
- Can be performed under local anaesthetic
- Symptom improvement typically within 2–4 weeks
Important Limitations
- Not suitable for median lobe enlargement — a very common anatomical pattern
- Not suitable for large prostates (generally over 80ml)
- Not suitable if urinary retention has occurred
- Symptom improvement less than TURP or Aquablation
- Long-term durability uncertain — significant re-treatment rates at 5 years
- Permanent implants remain in situ — implications for future MRI and any subsequent TURP
⚠️ Evidence — Durability & Re-treatment (L.I.F.T. Trial)
The primary RCT evidence for UroLift comes from the L.I.F.T. trial (Luminal Improvement Following Prostatic Tissue Approximation for the Treatment of LUTS). Five-year data shows approximately 13% of patients required surgical re-treatment, with symptom scores beginning to deteriorate in a proportion from year 2 onwards. The 10-year evidence base is limited. Men who subsequently require TURP may face technical difficulties due to retained implants — an important consideration for younger patients.
Who May Be Suitable
- Lateral lobe enlargement — no significant median lobe
- Prostate volume 30–80ml
- Moderate symptoms — not in retention
- Strong wish to preserve ejaculatory function
- Medically unfit for general anaesthetic
- Medication not tolerated or ineffective
Who Should NOT Have UroLift
- Median lobe enlargement (common — must be excluded by cystoscopy)
- Prostate volume over 80ml
- Urinary retention — current or recent
- Men planning future MRI surveillance for prostate cancer
- Men prioritising maximal and durable symptom relief
Rezūm — Water Vapour Thermal Therapy
Convective thermal energy delivered via steam to ablate prostatic tissue
Rezūm delivers precise bursts of steam into prostatic tissue through a cystoscopic device — causing cell death and tissue contraction over 4–12 weeks.
How It Works
Rezūm uses radiofrequency energy to convert water into steam (water vapour), which is injected in precise bursts into prostatic tissue via a cystoscopic device. The steam releases thermal energy on contact, causing cell death and subsequent tissue contraction over 4–12 weeks. Unlike UroLift, Rezūm destroys tissue — which produces more meaningful symptom improvement.
Potential Advantages
- Can treat median lobe — unlike UroLift
- No permanent implants left in situ
- Day case — often under local anaesthetic or light sedation
- Can treat larger prostates than UroLift
- Ejaculatory function preserved in most patients
- Meaningful symptom improvement over time
Important Limitations
- Catheter required for 1–2 weeks post-procedure — significant inconvenience
- Symptom improvement takes 4–12 weeks — not immediate
- Worsening of symptoms initially before improvement
- Long-term durability data limited — only 5-year RCT data available
- All major trial data sponsored by the device manufacturer (NxThera/Boston Scientific)
- Not suitable for patients in urinary retention
⚠️ Evidence — Durability & Re-treatment (Rezūm RCT)
The evidence for Rezūm comes from its own separate dedicated RCT (McVary et al.) which compared Rezūm to a sham procedure — not to TURP, and entirely separate from the WATER / WATER II trials (which are Aquablation trials). The Rezūm RCT has 5-year follow-up data showing durable improvement in the majority of patients. However, re-treatment was required in a proportion of patients, and crucially, all trial data has been sponsored by the device manufacturer — a potential source of bias. Ten-year outcomes are not yet available, and it is not yet possible to state definitively how Rezūm compares to TURP or Aquablation over the longer term.
Who May Be Suitable
- Prostate volume 30–150ml
- Including median lobe enlargement
- Moderate symptoms — not in retention
- Wish to preserve ejaculatory function
- Medication intolerant or failed medical therapy
- Medically unfit for general anaesthetic
Who Should NOT Have Rezūm
- Active urinary tract infection
- Urinary retention — Rezūm not suitable until resolved
- Implanted cardiac devices — pacemaker (relative contraindication)
- Men seeking immediate symptom relief
- Men unable to tolerate 1–2 weeks with a catheter post-procedure
Comparison
UroLift vs Rezūm vs Aquablation
An honest comparison across the procedures — including the one Mr. Jesuraj recommends and performs.
| Factor | UroLift | Rezūm | ★ Aquablation |
|---|---|---|---|
| Mechanism | Mechanical retraction — no tissue removal | Steam thermal ablation — tissue destroyed | Robotic waterjet — precise tissue excision, no heat |
| Median lobe | ✗ Not suitable | ✓ Yes | ✓ Yes — any anatomy |
| Prostate size | 30–80ml only | 30–150ml | All sizes including very large |
| Anaesthetic | Local or GA | Local or GA | Spinal or general anaesthetic |
| Post-op catheter | Usually none | 1–2 weeks required | 1–2 days |
| Time to benefit | 2–4 weeks | 4–12 weeks | Weeks |
| Ejaculation preserved | Most patients | Most patients | Significantly lower risk than TURP |
| Key trial evidence | L.I.F.T. RCT (vs sham) | Rezūm RCT — McVary et al. (vs sham) | WATER trial vs TURP · WATER II large prostates |
| Long-term evidence | 5 years — limited beyond this | 5 years — industry-sponsored | Robust — independent RCT vs TURP |
| 5-year re-treatment | ~13% (L.I.F.T.) | Reported low — longer-term data awaited | Very low — strong durability data |
| NICE approved | Yes | Yes (2018) | Yes — 2023 |
| Available at Tees Urology | Via referral to specialist | Via referral to specialist | ✓ Mr. Jesuraj performs |
Mr. Jesuraj’s Approach
Honest Guidance — Not a Procedure Recommendation
Mr. Jesuraj does not perform UroLift or Rezūm. This is a deliberate clinical decision — not a commercial one. He believes that for the majority of men suitable for surgical treatment of BPH, more definitive procedures offer significantly more durable outcomes.
However, minimally invasive procedures have a genuine and important role for men in the specific gap between medical therapy and definitive surgery. This includes men who:
- Cannot tolerate medication or in whom medication has failed, but whose symptoms are not yet severe enough for Aquablation or TURP
- Are medically unfit for general or spinal anaesthetic and need an office-based or local anaesthetic procedure
- Have a strong and absolute preference for ejaculatory preservation as the overriding priority
- Fully understand and accept the limitations around durability and potential re-treatment
“My job is to ensure every patient fully understands their options, the evidence supporting each, and the honest limitations — including that the WATER and WATER II trial data, which is the most robust independent RCT evidence for any of these procedures, relates to Aquablation versus TURP. In some patients, especially those presenting with retention of urine or high risk of bleeding, I would strongly recommend them to go for TURP or Holmium Laser Enucleation. The choice of treatment should be married up with the needs and wants of the individual patient. If after full discussion a patient chooses UroLift or Rezūm, I will arrange referral to an appropriate specialist. What I will not do is recommend a procedure I believe is less likely to give a durable result without being transparent about that.”
— Mr. Manohar Jesuraj, Consultant Urological Surgeon★ Mr. Jesuraj’s Recommendation for Surgical BPH Treatment
Aquablation — Definitive, Durable, Robotic Precision
For men with moderate to severe BPH symptoms who are candidates for surgical treatment, Mr. Jesuraj recommends and performs Aquablation — a robotic waterjet procedure proven in the independent WATER and WATER II RCTs against TURP. No heat. Effective for all prostate sizes including large glands. 96% patient satisfaction.
Patient satisfaction — WATER II trial (large prostates)
Independent RCT vs TURP — superior safety, non-inferior efficacy
Small, medium and large prostates including median lobe
Approved for NHS and private use
Get the Full Picture — Then Decide
A consultation with Mr. Jesuraj includes a thorough prostate assessment, review of all treatment options, and an honest recommendation. If you decide to proceed with UroLift or Rezūm, he will arrange referral to an appropriate specialist. Appointments within 7 days.